Cargando…

Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma

PURPOSE: Invasive pleomorphic lobular carcinoma (IPLC) is a very rare and distinct morphological variant of invasive lobular carcinoma (ILC), characterized by nuclear atypia and pleomorphism contrasted with the cytologic uniformity of ILC. This study evaluated clinicopathologic characteristics and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Seung Pil, Lee, Se Kyoung, Kim, Sangmin, Choi, Min-Young, Bae, Soo Youn, Kim, Jiyoung, Kim, Minkuk, Kil, Won Ho, Cho, Eun Yoon, Choe, Jun-Ho, Kim, Jung-Han, Kim, Jee Soo, Nam, Seok Jin, Lee, Jeong Eon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468785/
https://www.ncbi.nlm.nih.gov/pubmed/23091544
http://dx.doi.org/10.4048/jbc.2012.15.3.313
_version_ 1782245988610605056
author Jung, Seung Pil
Lee, Se Kyoung
Kim, Sangmin
Choi, Min-Young
Bae, Soo Youn
Kim, Jiyoung
Kim, Minkuk
Kil, Won Ho
Cho, Eun Yoon
Choe, Jun-Ho
Kim, Jung-Han
Kim, Jee Soo
Nam, Seok Jin
Lee, Jeong Eon
author_facet Jung, Seung Pil
Lee, Se Kyoung
Kim, Sangmin
Choi, Min-Young
Bae, Soo Youn
Kim, Jiyoung
Kim, Minkuk
Kil, Won Ho
Cho, Eun Yoon
Choe, Jun-Ho
Kim, Jung-Han
Kim, Jee Soo
Nam, Seok Jin
Lee, Jeong Eon
author_sort Jung, Seung Pil
collection PubMed
description PURPOSE: Invasive pleomorphic lobular carcinoma (IPLC) is a very rare and distinct morphological variant of invasive lobular carcinoma (ILC), characterized by nuclear atypia and pleomorphism contrasted with the cytologic uniformity of ILC. This study evaluated clinicopathologic characteristics and prognosis of IPLC compared with invasive ductal carcinoma (IDC). METHODS: We retrospectively reviewed the medical records of 35 patients with IPLC and 6,184 patients with IDC, not otherwise specified. We compared the clinicopathologic characteristics, relapse-free survival (RFS) and disease specific survival (DSS) of patients who were surgically treated between January 1997 and December 2010. RESULTS: Patients with IPLC presented at an older age with larger tumor size, worse histologic grade, higher rates of N3 stage, more multifocal/multicentric tumors, and more nipple-areolar complex involvement than those of patients with IDC. During the follow-up period, the IPLC group experienced five cases (14.3%) of disease recurrence and three cases (8.6%) of disease specific mortality compared with 637 cases (10.4%) of recurrence and 333 cases (5.4%) of disease specific mortality in the IDC group. Univariate analysis using the Kaplan-Meier method revealed that the IPLC group showed a significantly poorer prognosis than that of the IDC group (RFS, p=0.008; DSS, p<0.001). However, after adjusting for clinicopathologic factors, a multivariate analysis showed no statistical differences in RFS (p=0.396) and DSS (p=0.168) between the IPLC and the IDC groups. CONCLUSION: Our data suggest that patients with IPLC present with poor prognostic factors such as large tumor size, poor histologic grade and advanced stage at diagnosis. These aggressive clinicopathologic characteristics may result in poor clinical outcomes. Although our study could not link IPLC histology to poor prognosis, considering the aggressive characteristics of IPLC, early detection and considerate treatment, including proper surgical and adjuvant intervention, could be helpful for disease progression and survival.
format Online
Article
Text
id pubmed-3468785
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Korean Breast Cancer Society
record_format MEDLINE/PubMed
spelling pubmed-34687852012-10-22 Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma Jung, Seung Pil Lee, Se Kyoung Kim, Sangmin Choi, Min-Young Bae, Soo Youn Kim, Jiyoung Kim, Minkuk Kil, Won Ho Cho, Eun Yoon Choe, Jun-Ho Kim, Jung-Han Kim, Jee Soo Nam, Seok Jin Lee, Jeong Eon J Breast Cancer Original Article PURPOSE: Invasive pleomorphic lobular carcinoma (IPLC) is a very rare and distinct morphological variant of invasive lobular carcinoma (ILC), characterized by nuclear atypia and pleomorphism contrasted with the cytologic uniformity of ILC. This study evaluated clinicopathologic characteristics and prognosis of IPLC compared with invasive ductal carcinoma (IDC). METHODS: We retrospectively reviewed the medical records of 35 patients with IPLC and 6,184 patients with IDC, not otherwise specified. We compared the clinicopathologic characteristics, relapse-free survival (RFS) and disease specific survival (DSS) of patients who were surgically treated between January 1997 and December 2010. RESULTS: Patients with IPLC presented at an older age with larger tumor size, worse histologic grade, higher rates of N3 stage, more multifocal/multicentric tumors, and more nipple-areolar complex involvement than those of patients with IDC. During the follow-up period, the IPLC group experienced five cases (14.3%) of disease recurrence and three cases (8.6%) of disease specific mortality compared with 637 cases (10.4%) of recurrence and 333 cases (5.4%) of disease specific mortality in the IDC group. Univariate analysis using the Kaplan-Meier method revealed that the IPLC group showed a significantly poorer prognosis than that of the IDC group (RFS, p=0.008; DSS, p<0.001). However, after adjusting for clinicopathologic factors, a multivariate analysis showed no statistical differences in RFS (p=0.396) and DSS (p=0.168) between the IPLC and the IDC groups. CONCLUSION: Our data suggest that patients with IPLC present with poor prognostic factors such as large tumor size, poor histologic grade and advanced stage at diagnosis. These aggressive clinicopathologic characteristics may result in poor clinical outcomes. Although our study could not link IPLC histology to poor prognosis, considering the aggressive characteristics of IPLC, early detection and considerate treatment, including proper surgical and adjuvant intervention, could be helpful for disease progression and survival. Korean Breast Cancer Society 2012-09 2012-09-28 /pmc/articles/PMC3468785/ /pubmed/23091544 http://dx.doi.org/10.4048/jbc.2012.15.3.313 Text en © 2012 Korean Breast Cancer Society. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jung, Seung Pil
Lee, Se Kyoung
Kim, Sangmin
Choi, Min-Young
Bae, Soo Youn
Kim, Jiyoung
Kim, Minkuk
Kil, Won Ho
Cho, Eun Yoon
Choe, Jun-Ho
Kim, Jung-Han
Kim, Jee Soo
Nam, Seok Jin
Lee, Jeong Eon
Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
title Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
title_full Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
title_fullStr Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
title_full_unstemmed Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
title_short Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
title_sort invasive pleomorphic lobular carcinoma of the breast: clinicopathologic characteristics and prognosis compared with invasive ductal carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468785/
https://www.ncbi.nlm.nih.gov/pubmed/23091544
http://dx.doi.org/10.4048/jbc.2012.15.3.313
work_keys_str_mv AT jungseungpil invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT leesekyoung invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT kimsangmin invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT choiminyoung invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT baesooyoun invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT kimjiyoung invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT kimminkuk invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT kilwonho invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT choeunyoon invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT choejunho invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT kimjunghan invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT kimjeesoo invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT namseokjin invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma
AT leejeongeon invasivepleomorphiclobularcarcinomaofthebreastclinicopathologiccharacteristicsandprognosiscomparedwithinvasiveductalcarcinoma